Induction of Tregs by MDSCs in the settings of cancer and chronic inflammation provides another indirect mechanism that supports tumor progression, as tumor infiltrating Tregs have been shown to directly stimulate mammary cancer metastasis by interaction of receptor activator of NFκB (RANK) with RANK ligand on the Tregs (61). Here, TNFRSF11A is linked to cancer.